ES2109365T3 - Sustancia fr901451, procedimiento para su preparacion y su uso. - Google Patents

Sustancia fr901451, procedimiento para su preparacion y su uso.

Info

Publication number
ES2109365T3
ES2109365T3 ES92914787T ES92914787T ES2109365T3 ES 2109365 T3 ES2109365 T3 ES 2109365T3 ES 92914787 T ES92914787 T ES 92914787T ES 92914787 T ES92914787 T ES 92914787T ES 2109365 T3 ES2109365 T3 ES 2109365T3
Authority
ES
Spain
Prior art keywords
substance
pct
sec
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92914787T
Other languages
English (en)
Inventor
Hiroshi Hatanaka
Shigehiro Takase
Takashi Fujita
Masanori Okamoto
Masakuni Okuhara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2109365T3 publication Critical patent/ES2109365T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

SE PRESENTA UNA NUEVA SUBSTANCIA FR901451 QUE SE PRODUCE CULTIVANDO UNA ESTIRPE PRODUCTORA DE LA SUBSTANCIA FR901451 DEL GENERO "FLEXIBACTER" EN UN MEDIO NUTRIENTE, ESTA NUEVA SUBSTANCIA POSEE ACTIVIDAD INHIBIDORA DE LA ELASTASA DEL LEUCOCITO HUMANO.
ES92914787T 1991-07-22 1992-07-14 Sustancia fr901451, procedimiento para su preparacion y su uso. Expired - Lifetime ES2109365T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919115811A GB9115811D0 (en) 1991-07-22 1991-07-22 Fr901451 substance,process for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
ES2109365T3 true ES2109365T3 (es) 1998-01-16

Family

ID=10698774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92914787T Expired - Lifetime ES2109365T3 (es) 1991-07-22 1992-07-14 Sustancia fr901451, procedimiento para su preparacion y su uso.

Country Status (11)

Country Link
US (1) US5409701A (es)
EP (1) EP0596118B1 (es)
JP (1) JP3326793B2 (es)
AT (1) ATE159049T1 (es)
DE (1) DE69222644T2 (es)
DK (1) DK0596118T3 (es)
ES (1) ES2109365T3 (es)
GB (1) GB9115811D0 (es)
GR (1) GR3025250T3 (es)
TW (1) TW260609B (es)
WO (1) WO1993002203A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310789B1 (en) 1999-06-25 2001-10-30 The Procter & Gamble Company Dynamically-controlled, intrinsically regulated charge pump power converter
JP3820149B2 (ja) 1999-06-25 2006-09-13 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 動的切換可能な電力変換器
BR0013793A (pt) 1999-09-06 2002-05-14 Ono Pharmaceutical Co Medicamentos profiláticos e terapêuticos para doenças oftálmicas
AU7453700A (en) * 1999-10-12 2001-04-23 Fujisawa Pharmaceutical Co., Ltd. Remedies for intractable wound
US6370046B1 (en) 2000-08-31 2002-04-09 The Board Of Trustees Of The University Of Illinois Ultra-capacitor based dynamically regulated charge pump power converter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質ｔａｎ―１０５７，その製造法および用途

Also Published As

Publication number Publication date
GR3025250T3 (en) 1998-02-27
TW260609B (es) 1995-10-21
EP0596118B1 (en) 1997-10-08
US5409701A (en) 1995-04-25
DE69222644D1 (de) 1997-11-13
GB9115811D0 (en) 1991-09-04
DK0596118T3 (da) 1997-12-22
JPH06509232A (ja) 1994-10-20
DE69222644T2 (de) 1998-02-05
ATE159049T1 (de) 1997-10-15
WO1993002203A1 (en) 1993-02-04
JP3326793B2 (ja) 2002-09-24
EP0596118A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
ES2161279T3 (es) Nucleosidos y nucleotidos que contienen racimos de boro.
ES2097908T3 (es) Nuevas benzopiranonas, procedimiento para su preparacion y su utilizacion.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
EP0373132A3 (en) Database management system and method
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
CA2084881A1 (en) Controlled-Release Microbe Nutrients and Method for Bioremediation
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
FI864125A0 (fi) Heterocykliska foereningar och deras framstaellning samt anvaendning.
AU8927491A (en) Implant with a through passage
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
AU619330B2 (en) Nematicidal microorganisms, their isolation and their use as bio-nematicides
ES2051754T3 (es) Uso de derivados cetonicos en el tratamiento de la depresion.
CA2076555A1 (en) Pharmaceuticals for the treatment of rejection reactions in organ transplantations
BG50282A3 (en) Method for the preparation of l- carnitine in a microbiological way
DE69028320D1 (de) Illudin-analoge, verwendet als antitumormittel
DK0589949T3 (da) Hidtil ukendte peptider, fremgangsmåder til fremstilling heraf og anvendelse af disse
DK0596118T3 (da) Stof FR901451, fremgangsmåde til fremstilling deraf og anvendelse deraf
ES2074332T3 (es) Derivados de polihidroxiciclopentano, su preparacion y su uso terapeutico.
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
AU7186487A (en) Use of D. bardawil as a source of vitamin A and a yolk-color enhancing agent
SE8201128L (sv) Forfarande for reproduktion av virulent treponema pallidum i vevnadsk ultur
BR9510198A (pt) Composto azo pirazolona processo para a sua preparação e utilização do composto
BR9106762A (pt) Derivado de aldc e uso do mesmo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 596118

Country of ref document: ES